In vitro assessment of inter and intra batch variability of a breath‐enhanced jet nebulizer

In vitro assessment of inter and intra batch variability of a breath‐enhanced jet nebulizer

“…In vitro assessment of inter and intra batch variability of a breath-enhanced jet nebulizer Mariam Rehman * , Antony Hurren, Adam Metcalf, Ross Hatley From EAACI International Severe Asthma Forum (ISAF 2012) Gothenburg, Sweden. 11-13 October 2012 Background Guidelines recommend that patients presenting with acute severe asthma with life-threatening features receive the necessary high doses of β2-agonists via the nebulized route.The SideStream Plus (SS+; Philips Respironics) is a breath-enhanced nebulizer designed to maximize respirable output, while minimizing treatment time [1]. Prior to the introduction of a new version of nebulizer, various in vitro assessments, including inter and intra batch variability, are performed using a limited number of devices.…”